Cargando…

0329. Beneficial effects of azithromycin combined with ceftazidime without activity against P. aeruginosa in a murine sepsis model of peritonitis by Pseudomonas aeruginosa

Detalles Bibliográficos
Autores principales:	Pachón-Ibañez, ME, Díaz-Martín, A, Dominguez-Herrera, J, Labrador, G, Smani, Y, Pachón, J, Garnacho-Montero, J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4796854/ http://dx.doi.org/10.1186/2197-425X-2-S1-P18

Ejemplares similares

Effect of Hypoxia on the Pathogenesis of Acinetobacter baumannii and Pseudomonas aeruginosa In Vitro and in Murine Experimental Models of Infection
por: Gil-Marqués, María Luisa, et al.
Publicado: (2018)

In Vitro Activity of Pentamidine Alone and in Combination with Antibiotics against Multidrug-Resistant Clinical Pseudomonas aeruginosa Strains
por: Herrera-Espejo, Soraya, et al.
Publicado: (2020)

IgM-enriched immunoglobulin improves colistin efficacy in a pneumonia model by Pseudomonas aeruginosa
por: Cebrero-Cangueiro, Tania, et al.
Publicado: (2022)

Ceftazidime resistance in Pseudomonas aeruginosa is multigenic and complex
por: Ramsay, Kay A., et al.
Publicado: (2023)

Antivirulence activity of azithromycin in Pseudomonas aeruginosa
por: Imperi, Francesco, et al.
Publicado: (2014)

Increased therapeutic efficacy of combination of azithromycin and ceftazidime on Pseudomonas aeruginosa biofilm in an animal model of ureteral stent infection
por: Wang, Xianfeng, et al.
Publicado: (2016)

Carbapenem Combinations for Infections Caused by Carbapenemase-Producing Pseudomonas aeruginosa: Experimental In Vitro and In Vivo Analysis
por: Herrera-Espejo, Soraya, et al.
Publicado: (2022)

Ceftolozane–tazobactam- and ceftazidime–avibactam-resistant Pseudomonas aeruginosa mastoiditis
por: Jacobs, Jeremy, et al.
Publicado: (2020)

Review of Ceftazidime-Avibactam for the Treatment of Infections Caused by Pseudomonas aeruginosa
por: Daikos, George L., et al.
Publicado: (2021)

Reversion of Ceftazidime Resistance in Pseudomonas aeruginosa under Clinical Setting
por: Liu, Qi, et al.
Publicado: (2022)

Impact of Azithromycin on the Quorum Sensing-Controlled Proteome of Pseudomonas aeruginosa
por: Swatton, J. E., et al.
Publicado: (2016)

Mechanism of azithromycin inhibition of HSL synthesis in Pseudomonas aeruginosa
por: Zeng, Jianming, et al.
Publicado: (2016)

2254. Multicenter Evaluation of Ceftazidime–Avibactam for Multidrug-Resistant Pseudomonas aeruginosa Infections
por: Jorgensen, Sarah C J, et al.
Publicado: (2019)

Proteomic analysis of ceftazidime and meropenem-exposed Pseudomonas aeruginosa ATCC 9027
por: Ngo, Hong Loan, et al.
Publicado: (2023)

PA3297 Counteracts Antimicrobial Effects of Azithromycin in Pseudomonas aeruginosa
por: Tan, Hao, et al.
Publicado: (2016)

Could Azithromycin Be Part of Pseudomonas aeruginosa Acute Pneumonia Treatment?
por: Leroy, Anne-Gaëlle, et al.
Publicado: (2021)

In vivo translational assessment of the GES genotype on the killing profile of ceftazidime, ceftazidime/avibactam and meropenem against Pseudomonas aeruginosa
por: Gill, Christian M, et al.
Publicado: (2022)

Severe Keratitis Caused by Pseudomonas aeruginosa Successfully Treated with Ceftazidime Associated with Acetazolamide
por: Hue, Benoit, et al.
Publicado: (2009)

In vitro activities of cellulase and ceftazidime, alone and in combination against Pseudomonas aeruginosa biofilms
por: Kamali, Esmat, et al.
Publicado: (2021)

In vitro Activity of Pentamidine Alone and in Combination With Aminoglycosides, Tigecycline, Rifampicin, and Doripenem Against Clinical Strains of Carbapenemase-Producing and/or Colistin-Resistant Enterobacteriaceae
por: Cebrero-Cangueiro, Tania, et al.
Publicado: (2018)

Azithromycin: An Underappreciated Quinolone-Sparing Oral Treatment for Pseudomonas aeruginosa Infections
por: Ulloa, Erlinda R., et al.
Publicado: (2022)

The Distribution of Fitness Effects of Beneficial Mutations in Pseudomonas aeruginosa
por: MacLean, R. Craig, et al.
Publicado: (2009)

Comparison of efficiency of intravitreal ceftazidime and intravitreal cefepime in the treatment of experimental Pseudomonas aeruginosa endophthalmitis
por: Deniz, Nurettin, et al.
Publicado: (2013)

Continuous infusion versus intermittent infusion of ceftazidime for the treatment of pneumonia caused by Pseudomonas aeruginosa
por: Lorente, L, et al.
Publicado: (2005)

Emergence of Ceftazidime- and Avibactam-Resistant Klebsiella pneumoniae Carbapenemase-Producing Pseudomonas aeruginosa in China
por: Zhu, Yiwei, et al.
Publicado: (2021)

Ceftazidime/Avibactam versus Polymyxin B in the Challenge of Carbapenem-Resistant Pseudomonas aeruginosa Infection
por: Chen, Juan, et al.
Publicado: (2022)

Ceftazidime/Avibactam for the Treatment of Carbapenem-Resistant Pseudomonas aeruginosa Infection in Lung Transplant Recipients
por: Chen, Juan, et al.
Publicado: (2023)

Ceftazidime-assisted synthesis of ultrasmall chitosan nanoparticles for biofilm penetration and eradication of Pseudomonas aeruginosa
por: Zheng, Xiaoran, et al.
Publicado: (2023)

In vivo imaging of the lung inflammatory response to Pseudomonas aeruginosa and its modulation by azithromycin
por: Stellari, Fabio, et al.
Publicado: (2015)

Azithromycin Exhibits Activity Against Pseudomonas aeruginosa in Chronic Rat Lung Infection Model
por: Kumar, Manoj, et al.
Publicado: (2021)

Preparation, characterization and in vitro antimicrobial activity of liposomal ceftazidime and cefepime against Pseudomonas aeruginosa strains
por: Torres, Ieda Maria Sapateiro, et al.
Publicado: (2012)

Evaluation of Ceftazidime/Avibactam Administration in Enterobacteriaceae and Pseudomonas aeruginosa Bloodstream Infections by Monte Carlo Simulation
por: Dai, Yuanyuan, et al.
Publicado: (2021)

Comparison of In Vitro Activity of Ceftazidime-Avibactam and Imipenem-Relebactam against Clinical Isolates of Pseudomonas aeruginosa
por: Wang, Leilei, et al.
Publicado: (2023)

Draft Genome Sequences of Seven Multidrug-Resistant Acinetobacter baumannii Strains, Isolated from Respiratory Samples in Spain
por: Labrador-Herrera, Gema, et al.
Publicado: (2016)

Time-Kill Evaluation of Antibiotic Combinations Containing Ceftazidime-Avibactam against Extensively Drug-Resistant Pseudomonas aeruginosa and Their Potential Role against Ceftazidime-Avibactam-Resistant Isolates
por: Montero, María M., et al.
Publicado: (2021)

Attenuation of Pseudomonas aeruginosa biofilm formation by Vitexin: A combinatorial study with azithromycin and gentamicin
por: Das, Manash C., et al.
Publicado: (2016)

Effects of azithromycin on Pseudomonas aeruginosa isolates from catheter-associated urinary tract infection
por: XU, ZHI-GANG, et al.
Publicado: (2015)

Perspectives for clinical use of engineered human host defense antimicrobial peptides
por: Pachón-Ibáñez, María Eugenia, et al.
Publicado: (2017)

Persistent Bacteremia from Pseudomonas aeruginosa with In Vitro Resistance to the Novel Antibiotics Ceftolozane-Tazobactam and Ceftazidime-Avibactam
por: Gangcuangco, Louie Mar, et al.
Publicado: (2016)

Genomic Analysis of Ceftazidime/Avibactam-Resistant GES-Producing Sequence Type 235 Pseudomonas aeruginosa Isolates
por: Recio, Raúl, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gd3s6c52dso8bss7vsvuadbdkv